Zimmer Biomet Holdings (Zimmer Biomet Holdings) 5-Year Yield-on-Cost %

: 0.79 (As of Today)

View and export this data going back to 2001. Start your Free Trial

Zimmer Biomet Holdings's yield on cost for the quarter that ended in Dec. 2023 was 0.79.

The historical rank and industry rank for Zimmer Biomet Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:

ZBH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.56 Med: 0.81 Max: 1.15
Current: 0.79

During the past 13 years, Zimmer Biomet Holdings's highest Yield on Cost was 1.15. The lowest was 0.56. And the median was 0.81.

ZBH's 5-Year Yield-on-Cost % is ranked worse than
81.88% of 309 companies
in the Medical Devices & Instruments industry
Industry Median: 2.24 vs ZBH: 0.79

Competitive Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zimmer Biomet Holdings 5-Year Yield-on-Cost % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's 5-Year Yield-on-Cost % falls into.

Zimmer Biomet Holdings 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Zimmer Biomet Holdings is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Zimmer Biomet Holdings (NYSE:ZBH) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Zimmer Biomet Holdings 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zimmer Biomet Holdings (Zimmer Biomet Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (NYSE:ZBH) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

ZIM:Germany ZBH:Austria

Address

345 East Main Street, Warsaw, IN, USA, 46580

Website

https://www.zimmerbiomet.com

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Executives

Syed A. Jafry	director	345 E. MAIN STREET, WARSAW IN 46580
Sreelakshmi Kolli	director	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Christopher B Begley	director
Robert Hagemann	director	3 GIRALDA FARMS, MADISON NJ 07940
Michael W Michelson	director	2800 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Betsy J Bernard	director	711 HIGH STREET, DES MOINES IA 50392-0300
Arthur J Higgins	director	C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Chad F Phipps	officer: Assoc. Gen. Counsel, Corp. Sec	C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Zuilen Wilfred Van	officer: Pres, Europe, M. East & Africa	345 E. MAIN STREET, WARSAW IN 46580
Paul A Stellato	officer: VP, Controller & CAO	C/O XYLEM INC, 1 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Sang Yi	officer: President, Asia Pacific	345 E. MAIN STREET, WARSAW IN 46580
Lori Winkler	officer: SVP and CHRO	345 E. MAIN STREET, WARSAW IN 46580
Rachel Ellingson	officer: SVP & CSO	345 E MAIN STREET, WARSAW K7 46580
Bryan C Hanson	director, officer: President and CEO	ZIMMER BIOMET HOLDINGS, 345 E. MAIN STREET, WARSAW IN 46580
Aure Bruneau	officer: Group President	345 E. MAIN STREET, WARSAW IN 46580